Building Successful Life Science Companies with Katrina Rogers

About this episode

Katrina Rogers discusses her journey in life sciences and the challenges faced by female founders in biotech.

In this powerful episode of BioTalk Unzipped , Gregory Austin and Dr. Chad Briscoe sit down with Katrina Rogers, a 25-year life sciences veteran, biotech equity advocate, and founder of Evergreen Bioscience Innovation and Katrina Rogers Consulting. Katrina shares her compelling journey from Pfizer to pioneering innovation ecosystems and mentoring underrepresented biotech founders. They unpack the role of board governance, the funding gap for female founders, and how "showing your science" is critical for regulatory success. Katrina also warns of dangerous gaps in understanding between regulators and innovators and why we must protect our basic science infrastructure. If you've ever dreamed of launching a breakthrough therapy, leading a biotech, or making your idea count, this episode is for you. 00:00 Episode Preview & BioTalk Unzipped Introduction 03:09 Katrina’s Charity Highlight: 2nd Harvest (link below) 04:04 Defining Moment in Life Science 05:35 Launching a Consultancy: Overcoming Fears 07:12 Leadership Lessons 09:30 The Importance of Board Composition 13:08 NEW NEWS: The Case for Female Founders 18:04 Knowledge Gaps Between Founders and Regulators 20:23 The Impact of…

People in this episode

Hosts: Gregory Austin, Dr. Chad Briscoe

Guest: Katrina Rogers

Topics covered

• life sciences
• biotech innovation
• female founders
• regulatory challenges
• board governance
• mentorship

Keywords

• life sciences
• biotech
• female founders
• regulatory success
• innovation ecosystems
• board governance
• mentorship

Mentioned in this episode

Organizations: Evergreen Bioscience Innovation, Katrina Rogers Consulting, Pfizer, 2nd Harvest

More episodes of BioTalk Unzipped

• The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi · June 11, 2026 · 30 min
• Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker · April 25, 2026 · 51 min
• Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains · March 19, 2026 · 1h 0m
• The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney · February 16, 2026 · 53 min
• Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins · December 22, 2025 · 49 min
• Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva · October 23, 2025 · 31 min